New ALS Treatment, AMX0035, Lacks Evidence of Benefit, FDA Panel Findsnews2022-03-30T22:45:15+00:00March 30th, 2022|The New York Times|
Ivermectin Does Not Reduce Risk of Covid Hospitalization, Large Study Findsnews2022-03-30T21:12:29+00:00March 30th, 2022|The New York Times|
How to Prepare for BA.2, the Omicron Subvariantnews2022-03-30T18:57:02+00:00March 30th, 2022|The New York Times|
F.D.A. Allows Second Coronavirus Boosters for Everyone 50 and Oldernews2022-03-29T23:44:53+00:00March 29th, 2022|The New York Times|
Alopecia Hair Loss: What to Know About Jada Pinkett Smith’s Conditionnews2022-03-28T21:52:30+00:00March 28th, 2022|The New York Times|
Biden Administration Plans to Offer Second Booster Shots to Those 50 and Upnews2022-03-26T14:29:54+00:00March 26th, 2022|The New York Times|
F.D.A. Rushed a Drug for Preterm Births. Did It Put Speed Over Science?news2022-03-25T15:15:07+00:00March 25th, 2022|The New York Times|
Moderna to Seek Authorization of Its Coronavirus Vaccine for Young Childrennews2022-03-23T22:18:57+00:00March 23rd, 2022|The New York Times|
Pfizer Recalls Some Blood Pressure Drugs, Citing Cancer Risknews2022-03-23T20:29:21+00:00March 23rd, 2022|The New York Times|
With a lot of the world yet to be vaccinated, protesters demand that the technology be shared.news2022-03-12T16:18:01+00:00March 12th, 2022|The New York Times|
